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Abstract
Background:  To evaluate the clinical outcome of primary endonasal laser assisted
dacryocystorhinostomy (ENL-DCR) using the potassium-titanyl-phosphate laser.
Methods: We retrospectively reviewed all primary ENL-DCRs performed within a period of
twelve months by the same combined Ophthalmology and Otorhinolaringology team in Freeman
Hospital, Newcastle upon Tyne, UK. The main outcome measure for success was resolution or
significant improvement of epiphora. Details of surgery, intraoperative and postoperative
complications, as well as pathology associated with failure w e r e  a l s o  s t u d i e d .  P a t i e n t s  w e r e
followed up for at least 12 months.
Results: A total of 41 consecutive ENL-DCRs on 29 patients (22 females, 7 males, mean age 75
years) were analysed. All patients had bicanalicular silicone intubation for at least 4 months. The
success rate at 12 months postoperatively was 78.1%. Pathology associated with failure included:
intranasal pathology (12.2%), mucocele (7.3%), and systemic sarcoidosis (2.4%). No significant intra-
operative complications were recorded.
Conclusion: The ENL-DCR with potassium-titanyl-phosphate laser can be considered as a safe
and efficient primary procedure for the treatment of nasolacrimal duct obstruction.
Background
Dacryocystorhinostomy (DCR) is the treatment of choice
for patients with chronic stenosis and obstruction of the
nasolacrimal duct. External dacryocystorhinostomy (EXT-
DCR) was first described by Toti [1,2] in 1904. The endo-
nasal approach was first introduced in 1893 by Caldwell
[3,4], but it was inherently limited by poor visibility of
endonasal anatomy during surgery. The introduction of
high-resolution fiberoptic endoscopes in the late 1980s
enabled adequate visualisation of the nasal cavities, and
permitted minimally invasive surgery, under local anaes-
thesia, avoiding visible facial scarring[5,6]. Endonasal
dacryocystorhinostomy (ENL-DCR) can be performed
either entirely surgically[7] or with the assistance of laser
to create the fistula. Massaro, Gonnering and Haris [8,9]
were the first to describe the endonasal
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dacryocystorhinostomy (ENL-DCR), using Argon laser for
the creation of the DCR fistula. Since then, carbon dioxide
(CO2), holmium:Yag (Ho:Yag), neodymium:Yag
(Nd:Yag), and potassium-titanyl-phosphate (KTP) laser
systems have been employed in an attempt to identify the
optimal delivery system that would achieve sufficient
bone ablation with effective haemostasis[10].
Reported primary ENL-DCR success rates vary from 68%
to 99% [5,6,11], depending on the type of laser, the size
of the osteotomy and the use of antimetabolites, such as
mitomycin C [12]. In this study, we evaluate the clinical
outcome of 41 consecutive primary ENL-DCRs that were
performed on 29 patients using the KTP laser over a
period of one year.
Methods
The records of all 47 ENL-DCR procedures that were per-
formed in Freeman Hospital, Newcastle upon Tyne,
United Kingdom, within a period of twelve months were
retrospectively studied. The patients' main symptom was
moderate to severe epiphora. Obstruction of the nasolac-
rimal system distal to the lacrimal sac was diagnosed with
nasolacrimal syringing. Radiographic imaging was not
part of the routine preoperative evaluation. Otorhi-
nolaryngological preoperative assessment included full
endoscopic examination of nasal cavities, looking for evi-
dence of mucosal disease including polyps particularly in
the middle meati. Exclusion criteria for ENL-DCR were:
noticeable lower lid laxity, previous lacrimal surgery, sus-
picion of malignancy and previous radiation therapy.
Each patient with primary nasolacrimal duct obstruction
was counselled as to the advantages and disadvantages of
EXT- DCR versus ENL-DCR, together with estimated suc-
cess rates of the two different types of DCR. The opera-
tions were performed by the same ophthalmologist
(C.N.) and ENT surgeon (S.C.). The majority of patients
had surgery under local anaesthesia on an outpatient
basis, except for one who opted for general anaesthesia.
For local anaesthesia, Amethocaine drops were instilled in
the conjunctival sac, followed by injection of Xylocaine
2% with 1:200000 Adrenaline in the medial third of both
eyelids and transcaruncularly to the lacrimal sac. Cophe-
nylcaine spray and intranasal cocaine 4% paste was
applied to achieve anaesthesia and haemostasis. Dilata-
tion of the lower punctum was performed and a 20G vit-
reoretinal probe was inserted in the lower canaliculus and
advanced into the nasolacrimal sac. The light was directly
visualised endonasally with a 0° rigid nasal endoscope,
and the laser energy was delivered, with full laser precau-
tions, via a KTP laser probe guided by the light. The nasal
mucosa and lacrimal bone were ablated and the ostium
was enlarged anteriory as necessary with a microronguer.
Bicanalicular O'Donoghue silicone tubes were inserted
and secured with a Watzke sleeve. A course of topical
Chloramphenicol drops was given for 1 week. Patients
were examined 1 week postoperatively and then at 6
months for removal of tubes, or earlier, if discomfort was
experienced. Mean follow up period was 16 months
(range 12–24 months).
Results
Forty- seven consecutive primary ENL-DCR operations
with lacrimal intubation were performed from March
2001 to February 2002 on 35 patients with primary
acquired nasolacrimal duct obstruction. Five cases with
incomplete follow up and one which had to be converted
to EXT-DCR due to very thick lacrimal bone were excluded
from the study. Forty-one ENL-DCR procedures on 29
patients (7 males and 22 females) were included in the
study. Mean age was 75 years (range 47–90, SD 13.7). 12
patients (41.4%) underwent simultaneous bilateral sur-
gery and 17 (58.6%) had unilateral ENL-DCR. In total, 19
right sided (46.3%) and 22 left sided (53.7%) procedures
were recorded (Table 1).
Pre-operatively, all patients were suffering from signifi-
cant epiphora, which was affecting their quality of life.
Mucocele was present in 6 cases (14.6%) and previous
dacryocystitis in 4 (9.8%), while in another 3 cases (7.3%)
these two conditions co-existed (Table 2). Mild medial
ectropion was noted in 5 cases (12.1%) and intranasal
pathology (including sinus disease, deviated nasal sep-
tum, polypoidal medial turbinate and previous nasal frac-
tures) in 7 cases (17.1%). Two patients (4.8%) had
systemic sarcoidosis.
During the operation the mean laser energy used was
400.2 joules (range 96–797, SD 188.5). Serious intra-
operative complications did not occur, although in some
Table 1: Characteristics of the study group
Number of patients/procedures 29/41
Mean age (years) 75
Range of age 47–90 (mean, 75)
Male:Female ratio 7:22
Laterality of surgery (right/left) 19/22
Simultaneous bilateral (patients) 12
Table 2: Pre-operative lacrimal drainage system abnormalities
NLD obstruction with epiphora 41 (100%)
Mucocele 6 (14.6%)
Dacryocystitis 4 (9.7%)
Mucocele and Dacryocystitis 3 (7.3%)BMC Ophthalmology 2005, 5:2 http://www.biomedcentral.com/1471-2415/5/2
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patients' records per-operative mild discomfort was
documented.
The removal of silicone tubes was scheduled at 6 months
post-operatively, though in ten patients extubation was
performed at 1–4 months due to discomfort. In two
patients, mild nasal haemorrhage was noted on removal
of tubes.
The operation was defined as being successful if the
patient was asymptomatic or if there was significant
improvement of symptoms, not requiring any additional
procedure. Success rate at 12 months postoperatively was
78.1%. No improvement of symptoms was noted in 8
patients (19.5%), while 1 patient reported worsening of
epiphora (Table 3). Pathology associated with failure (9
cases – 21.9%) included: intranasal pathology (sinus dis-
ease, septum deviation, polypoidal medial turbinate and
previous nasal fracture) in 5 cases (55.5%), mucocele in 3
cases (33.3%), and systemic sarcoidosis in 1 case (11.2%)
(Table 4). EXT-DCR or treatment of the nasal pathology
was offered to all patients with persistent epiphora.
Discussion
ENL-DCR is a well established surgical technique with
some advantages compared to the conventional EXT-
DCR. These include limitation of tissue injury to the dis-
crete fistula site, avoidance of a skin incision, excellent
haemostasis, the ability to perform a lacrimal bypass
operation on an outpatient basis, quicker patient rehabil-
itation, decreased overall health care expense and
patients' preference [8,13]. Main limitations of the tech-
nique are its steep learning curve, the higher equipment
cost and its contraindication in cases of severe pre-existing
nasal deformities or scarring and suspected lacrimal sac
neoplasms [13].
ENL-DCR avoiding the use of laser is a well described pro-
cedure. Several surgical instruments have been employed
to remove the bone overlying the lacrimal sac, including
drills, osteotomes, curettes and rongeurs. Weidenbecher
reported resolution or improvement of symptoms in 95%
of the patients[6]. In another study of surgical ENL-DCR
results, Sprekelsen achieved good results on 96% of the
operations[5]. Both studies describe no major complica-
tions associated with the technique.
Various types of laser (Argon, CO2, Ho:Yag, Nd:Yag), have
been employed in an attempt to achieve better bone abla-
tion and haemostasis. Massaro et al [8] and Christenbury
[14] reported a 70% success rate using an argon blue laser,
but they both encountered difficulties in creating an ade-
quate osteotomy. A prospective randomised comparison
of EXT-DCR and ENL-DCR with the CO2-Nd:Yag laser by
Hartikainen et al [15] revealed far superior results of the
external approach (91% success compared to 63% with
the endonasal technique), admitting though that their
ENL-DCR technique was possibly suboptimal. Szubin et
al [10] achieved an impressive successs rate of 97% with
the Ho:Yag laser. This laser seems to outperform the rest,
delivering better haemostasis and ablation, but its cost is
higher and it is not so diverse in its applications [10].
The KTP laser, already utilised by ENT surgeons in other
procedures, offers excellent haemostasis but its ablating
properties are relatively poor, thus requiring the use of a
microrongeur if the underlying bone is thick [16]. Mirza
et al [17] reported improvement of symptoms in 64% of
patients by KTP laser ENL-DCR, rising to 82 % including
revision procedures. Using the same type of laser, Reifler
found 68% success rate in a retrospective study of 19
cases, with a longer follow up of 10–16 months [18].
Interestingly, though, he noted that the first 10 cases
showed a success rate of only 50%, compared to 89% in
the following 9 cases. This observation reflects the steep
learning curve of this technique. Mickelson et al [19]
reported a series of 19 patients with 100% success (follow
up 5–25 months). Hofmann et al [2] performed ENL-
DCR with KTP using miniendoscopes to visualise the
exact site of obstruction, and achieved success rate of 83%
at one year follow up.
In our experience, the success rate of primary ENL-DCR
using the KTP laser at 12 months was 78.1%. We defined
success as complete resolution of epiphora or improve-
ment of symptoms with no further procedure required, as
this outcome carries the most significant implication on
the patient's quality of life. The anatomic result was not
evaluated at postoperative follow up, as the healed intra-
Table 3: Success rate
Asymptomatic 17 (41.5%)
Significant improvement (no further procedure 
required)
15 (36.6%)
Symptoms unchanged 8 (19.5%)
Symptoms deteriorated 1 (2.4%)
Total success 32 (78.1%)
Table 4: Pathology associated with failure
Intranasal pathology (sinus disease, septum deviation, 




Sarcoidosis 1 (11.2%)BMC Ophthalmology 2005, 5:2 http://www.biomedcentral.com/1471-2415/5/2
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nasal ostium size and patency do not always correlate
with symptomatic relief. A significant number of patients
have been reported to have symptoms in spite of a patent
fistula (54% for EXT-DCR and 39% for ENL-DCR)[20],
where in some cases, paradoxically, resolution of symp-
toms is achieved despite a negative fluorescein test [21].
As the aim of our study was to evaluate the results of pri-
mary procedures only, repeat procedures were excluded.
The optimum duration of stent retention following DCR
is controversial. In published series it varies from 4 weeks
to 6 months, though there is some evidence that pro-
longed silicone intubation may increase the incidence of
DCR failure by inciting a granulomatous reaction at the
internal ostium, with subsequent stenosis [22]. All our
patients underwent lacrimal intubation with silicone
tubes, and in most cases the tubes were removed at 6
months postoperatively. Early extubation (1–4 months)
was necessary in 10 cases due to discomfort, and the oper-
ation failed in 2 of them (20%). Thus, in our experience,
early removal of silicone tubes was not associated with
lower success rate.
Reported pre-operative risk factors for ENL-DCR failure
include pre-existing sinus disease, mucocele, nasal sep-
tum deviation, connective tissue diseases such as sar-
coidosis, previous EXT-DCR, other nasal surgery, nasal
fracture, and thickened lacrimal bone [23]. In our series,
failure was associated mostly with intranasal pathology
(sinus disease, septum deviation, polypoidal medial tur-
binate and previous nasal fracture), but also with
mucocele and sarcoidosis (table 4). Radiographic imag-
ing, particularly CT DCG or CT of nose and sinuses could
be of potential help in clarifying the extent of concomi-
tant sinus and nasal disease and increase our success rate.
However, as this would add to the cost and the complexity
of the preoperative assessment in a busy clinical setting
[24], it was not part of our routine evaluation. The com-
mon outcome in the failed cases is blockage of the ostium
due to cicatrisation, adhesions between the ostium and
the medial turbinate, synechiae between the ostium and
the septum, or granuloma formation within the ostium
[22]. Opinions differ about size and location, with some
surgeons favouring smaller ostium size at the lower thin-
ner part of the lacrimal bone [25], while others recom-
mend larger size and removal of the thicker frontal
process of the maxilla [6,26]. The ideal technique is yet to
be defined.
It has been proposed that the thermal energy produced by
the laser may lead to scarring and subsequent blockage of
the ostium [10]. It has also been suggested that the
adjunctive intra-operative application of Mitomycin C
(MMC) can be considered in high risk cases or primary
failures, as it appears to be safe and efficient in improving
the patency rate [9].
ENL-DCR performed under local anaesthesia is reported
to be generally well tolerated by the patients[27]. In our
study, all operations were performed under local anaes-
thesia, except for one patient who opted for general anaes-
thesia. No significant discomfort was reported by any of
our patients, which confirms the reported positive
patients' views. Reported complications associated with
ENL-DCR include per-operative or post-operative haem-
orrhage, punctal erosion related to silicone intubation, sil-
icone tubing prolapse, canalicular obstruction, orbital fat
herniation, orbital and subcutaneous emphysema, con-
junctival fistula formation, retrobulbar haemorrhage, and
transient medial rectus paresis (23). In our series, no
severe per-operative or post-operative complications were
encountered. The only documented complications were
discomfort caused by the silicone tubes in 10 patients
requiring early extubation, and mild, transient nasal
haemorrhage during removal of the silicone tubes in 2
patients.
In our experience, the use of KTP laser in ENL-DCR under
local anaesthesia with the adjunctive use of an osteotome
is a safe and efficient technique, with good results. The
particular advantages of this laser are its superior haemo-
static properties and its diversity, which reduces the cost of
the operation, as it is already employed in other proce-
dures by the ENT surgeons. Significant complications are
not common with this technique. In cases of failure, revi-
sion ENL-DCR or EXT- DCR can be performed. ENL-DCR
with KTP laser is routinely performed under local anaes-
thesia, thus avoiding the risks of general anaesthesia usu-
ally required for EXT-DCR [24] The operative time is also
shorter compared to the EXT- DCR [16].
Conclusion
ENL-DCR using KTP laser appears to be an efficient tech-
nique, with low complication rate and it is well tolerated
by the patients. It still needs refinement in order to
achieve the higher success rate of the EXT- DCR, which
remains the gold standard method for the treatment of
nasolacrimal duct obstruction. At present, we believe that
patients should be involved in the decision on the type of
operation, after comprehensive consultation on the
advantages and disadvantages of each technique.
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